Radiomultiomics: quantitative CT clusters of severe asthma associated with multi-omics.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 01 02 2024
accepted: 21 07 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Lung quantitative computed tomographic (qCT) severe asthma clusters have been reported, but their replication and underlying disease mechanisms are unknown. We identified and replicated qCT clusters of severe asthma in two independent asthma cohorts and determined their association with molecular pathways. We used consensus clustering on qCT measurements of airway and lung CT scans, performed in 105 severe asthmatic adults from the U-BIOPRED cohort. The same qCT measurements were used to replicate qCT clusters in a subsample of the ATLANTIS asthma cohort (n=97). We performed integrated enrichment analysis using blood, sputum, bronchial biopsies, bronchial brushings and nasal brushings transcriptomics and blood and sputum proteomics to characterize radiomultiomic-associated clusters (RACs). qCT clusters and clinical features in U-BIOPRED were replicated in the matched ATLANTIS cohort. In the U-BIOPRED cohort, RAC1 (n=30) was predominantly female with elevated BMI, mild airflow limitation, normal qCT parameters and upregulation of the complement pathway. RAC2 (n=34) subjects had a lower degree of airflow limitation, airway wall thickness and dilatation, with upregulation of proliferative pathways, including neurotrophic receptor tyrosine kinase 2/tyrosine kinase receptor B (NTRK2/TRKB), and down-regulation of semaphorin pathways. RAC3 (n=41) showed increased lung attenuation area and air trapping, severe airflow limitation, hyperinflation, and upregulation of cytokine signaling and signaling by interleukin pathways, and matrix metallopeptidase 1, 2 and 9. U-BIOPRED severe asthma qCT clusters were replicated in a matched independent asthmatic cohort and associated with specific molecular pathways. Radiomultiomics might represent anovel strategy to identify new molecular pathways in asthma pathobiology.

Identifiants

pubmed: 39401856
pii: 13993003.00207-2024
doi: 10.1183/13993003.00207-2024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.

Auteurs

Nazanin Zounemat Kermani (NZ)

Data Science Institute, Imperial College, London, UK.

Kian Fan Chung (KF)

National Heart and Lung Institute, Imperial College London, London, UK.
Royal Brompton and Harefield Hospitals, London, UK.

Giuseppe Macis (G)

Radiology, Faculty of Medicine, Catholic University of the Sacred Heart, Roma, Italy.

Giuseppe Santini (G)

Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Roma, Italy.

Franz A A Clemeno (FAA)

Depatment of Respiratory Sciences. University of Leicester, Leicester, United Kingdom.

Ali Versi (A)

Data Science Institute, Imperial College, London, UK.

Kai Sun (K)

Data Science Institute, Imperial College, London, UK.

Mahmoud I Abdel-Aziz (MI)

Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Lars I Andersson (LI)

Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden.

Charles Auffray (C)

European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Université de Lyon, France.

Yusef Badi (Y)

Data Science Institute, Imperial College, London, UK.

Per Bakke (P)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Chris Brightling (C)

Institute for Lung Health, NIHR Leicester Biomedical Research Centre, Department of Respiratory Sciences, University of Leicester, Leicester, UK.

Paul Brinkman (P)

Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Massimo Caruso (M)

Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.

Pascal Chanez (P)

Assistance publique des Hôpitaux de Marseille - Clinique des bronches, allergies et sommeil, Aix Marseille Université, Marseille, France.

Bertrand De Meulder (B)

European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Université de Lyon, France.

Ratko Djukanovic (R)

NIHR Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, Southampton, UK.

Leonardo Fabbri (L)

Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Stephen J Fowler (SJ)

Division of infection, immunity and respiratory medicine, School of biological sciences, University of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Ildiko Horvath (I)

Semmelweis University, Budapest, Hungary.

Peter Howarth (P)

NIHR Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, Southampton, UK.

Anna J James (AJ)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Johan Kolmert (J)

Institute of Environmental Medicine, Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.

Monica Kraft (M)

Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Chuan-Xing Li (CX)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Anke H Maitland-van der Zee (AH)

Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Mario Malerba (M)

Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Alberto Papi (A)

Division of infection, immunity and respiratory medicine, School of biological sciences, University of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Klaus Rabe (K)

LungenClinic Grosshansdorf and Department of Medicine, Christian Albrechts University, Airway Research Center North within the German Center for Lung Research (DZL), Kiel, Germany.

Marek Sanak (M)

Division of Clinical Genetics and Molecular Biology, Department of Medicine, Jagiellonian University Medical College, Kraków, Poland.

Dominick E Shaw (DE)

Respiratory Research Unit, University of Nottingham, UK.

Dave Singh (D)

Centre for Respiratory Medicine and Allergy, Manchester University NHS Foundation Hospital Trust, University of Manchester, Manchester, UK.

Maria Sparreman Mikus (MS)

Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Maarten van Den Berge (M)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Asa M Wheelock (AM)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Craig E Wheelock (CE)

Institute of Environmental Medicine, Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.

Valentyna Yasinska (V)

Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden.

Yi-Ke Guo (YK)

Data Science Institute, Imperial College, London, UK.

Scott Wagers (S)

Biosci Consulting, Maasmechelen, Belgium.

Peter J Barnes (PJ)

National Heart and Lung Institute, Imperial College London, London, UK.

Andrew Bush (A)

National Heart and Lung Institute, Imperial College London, London, UK.

Peter J Sterk (PJ)

Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Sven-Erik Dahlen (SE)

Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden.
Institute of Environmental Medicine, Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.

Ian M Adcock (IM)

National Heart and Lung Institute, Imperial College London, London, UK.

Salman Siddiqui (S)

National Heart and Lung Institute, Imperial College London, London, UK.

Paolo Montuschi (P)

National Heart and Lung Institute, Imperial College London, London, UK ian.adcock@imperial.ac.uk.
Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Roma, Italy.

Classifications MeSH